A refined molecular taxonomy of breast cancer von Guedj, M, Marisa, L, de Reynies, A, Orsetti, B, Schiappa, R, Bibeau, F, MacGrogan, G, Lerebours, F, Finetti, P, Longy, M, Bertheau, P, Bertrand, F, Bonnet, F, Martin, A L, Feugeas, J P, Bièche, I, Lehmann-Che, J, Lidereau, R, Birnbaum, D, Bertucci, F, de Thé, H, Theillet, C

Volltext

Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer von Groheux, David, Biard, L., Lehmann-Che, J., Teixeira, L., Bouhidel, F. A., Poirot, B., Bertheau, P., Merlet, P., Espié, M., Resche-Rigon, M., Sotiriou, C., de Cremoux, P.

Volltext

Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab von Cizkova, M, Dujaric, M-E, Lehmann-Che, J, Scott, V, Tembo, O, Asselain, B, Pierga, J-Y, Marty, M, de Cremoux, P, Spyratos, F, Bieche, I

Volltext

Prognosis and molecular characteristics of IBD-associated colorectal cancer: Experience from a French tertiary-care center von Hammoudi, N., Lehmann-Che, J., Lambert, J., Amoyel, M., Maggiori, L., Salfati, D., Tran Minh, M.L., Baudry, C., Asesio, N., Poirot, B., Lourenco, N., Corte, H., Allez, M., Aparicio, T., Gornet, J.M.

Volltext

BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy von Hamy, A. S., Bieche, I., Lehmann-Che, J., Scott, V., Bertheau, Ph, Guinebretière, J. M., Matthieu, M. C., Sigal-Zafrani, B., Tembo, O., Marty, M., Asselain, B., Spyratos, F., de Cremoux, P.

Volltext

Les patients long-survivants d’un glioblastome ne présentent que très rarement la mutation IDH von Mandonnet, E, Amelot, A, De Cremoux, P, Polivka, M, Adle-Biassette, H, Lehmann-Che, J, George, B, Carpentier, A, Froelich, S

Volltext

Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen von Giacchetti, S, Porcher, R, Lehmann-Che, J, Hamy, A-S, de Roquancourt, A, Cuvier, C, Cottu, P-H, Bertheau, P, Albiter, M, Bouhidel, F, Coussy, F, Extra, J-M, Marty, M, de Thé, H, Espié, M

Volltext

Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches von Lehmann-Che, J, Amira-Bouhidel, F, Turpin, E, Antoine, M, Soliman, H, Legres, L, Bocquet, C, Bernoud, R, Flandre, E, Varna, M, de Roquancourt, A, Plassa, L-F, Giacchetti, S, Espié, M, de Bazelaire, C, Cahen-Doidy, L, Bourstyn, E, Janin, A, de Thé, H, Bertheau, P

Volltext

Les virus foamy, un modèle rétroviral original von LEHMANN-CHE, J, RENAULT, N, GIRON, M.-L, SAÏB, A

Volltext

Caractérisation clinique biologique et moléculaire de l’acropulpite dans le lupus érythémateux systémique : une nouvelle entité associée à une signature interféron élevée... von Sonigo, G.G., Cassius, C., Battistella, M., Le Buanec, H., Bagot, M., Saussine, A., De Masson, A., Lehmann Che, J., Jachiet, M., Bouaziz, J.-D.

Volltext

Challenging single- and multi-probesets gene expression signatures of pathological complete response to neoadjuvant chemotherapy in breast cancer: Experience of the REMAGUS 02 phas... von Valet, F, de Cremoux, P, Spyratos, F, Servant, N, Dujaric, M.E, Gentien, D, Lehmann-Che, J, Scott, V, Sigal-Zafrani, B, Mathieu, M.C, Bertheau, P, Guinebretière, J.M, Pierga, J.Y, Delaloge, S, Giacchetti, S, Brain, E, Tembo, O, Marty, M, Asselain, B

Volltext

P-006 Prognostic value of TP53 gene mutations in higher-risk MDS treated with azacitidine (AZA) von Bally, C, Ades, L, Renneville, A, Mozziconacci, M.J, Preudhomme, C, DeThé, H, Lehmann-Che, J, Fenaux, P

Volltext

Protease-Dependent Uncoating of a Complex Retrovirus von Lehmann-Che, Jacqueline, Giron, Marie-Lou, Delelis, Olivier, Loechelt, Martin, Bittoun, Patricia, Tobaly-Tapiero, Joelle, de The, Hugues, Saieb, Ali

Volltext

P-023 Incidence and prognostic value of TP53 mutations in IPSS low and INT 1 (lower risk) MDS with del 5q von Bally, C, Ades, L, Renneville, A, Preudhomme, C, Raynaud, S, Cluzeau, T, Eclache, V, Hunault-Berger, M, Stamoullas, A, Fontenay, M, Mozziconacci, M.J, De Thé, H, Fenaux, P, Lehmann-Che, J

Volltext

Resistance to Therapy in Acute Promyelocytic Leukemia von Lehmann-Che, Jacqueline, Bally, Cecile, de Thé, Hugues

Volltext

Cellular MicroRNA Mediates Antiviral Defense in Human Cells von Lecellier, Charles-Henri, Dunoyer, Patrice, Arar, Khalil, Lehmann-Che, Jacqueline, Eyquem, Stephanie, Himber, Christophe, Sai̊b, Ali, Voinnet, Olivier

Volltext

Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine von Bally, Cecile, Adès, Lionel, Renneville, Aline, Sebert, Marie, Eclache, Virginie, Preudhomme, Claude, Mozziconacci, Marie-Joelle, de The, Hugues, Lehmann-Che, Jacqueline, Fenaux, Pierre

Volltext

71P MicroRNA (miRNA) a putative biomarker to better define the molecular apocrine breast cancer (MABC) subtype von Chamandi, G., Nasr, R., Lehmann-Che, J., Le Bras, M.

Volltext

483P Prognostic value of androgen receptor expression in patients with advanced triple-negative metastatic breast cancer treated with sacituzumab govitecan: A French multicentre re... von Arnedos, M., Segier, B., Vincent, N., Robert, M., Grinda, T., Grellety, T., Deluche, E., Lehmann-Che, J., Jacot, W., Heymann, M-F., Lusque, A., Brunet, M., Teixeira, L., Guiu, S.

Volltext

768P Reclassification and variant distribution in the GINECO GREAT study of ovarian cancer patients: Insights into HRD status von Rouleau, E., Soubeyran, I., Haddad, V., Harter, V., Buisson, A., Boidot, R., Chevalier, L.M., Lespagnol, A., Callens, C., Manz, S., Lamy, P.J., Leroy, K., Tallet, A., Laghmari, O., Lehmann-Che, J., Toulas, C., Harlé, A., Pujade-Lauraine, E., De La Motte Rouge, T., Vaur, D.

Volltext